Craig-Hallum Downgrades Edgio to Hold, Lowers Price Target to $1
Craig-Hallum analyst Jeff Van Rhee downgrades Edgio (NASDAQ:EGIO) from Buy to Hold and lowers the price target from $2.5 to $1.
BMO Capital Maintains Market Perform on Public Service Enterprise, Lowers Price Target to $60
BMO Capital analyst James Thalacker maintains Public Service Enterprise (NYSE:PEG) with a Market Perform and lowers the price target from $64 to $60.
Guggenheim Maintains Buy on Progress Software, Raises Price Target to $64
Guggenheim analyst John Healy maintains Progress Software (NASDAQ:PRGS) with a Buy and raises the price target from $60 to $64.
B. Riley Securities Maintains Neutral on Ashford Hospitality Trust, Lowers Price Target to $6.5
B. Riley Securities analyst Alex Kurtz maintains Ashford Hospitality Trust (NYSE:AHT) with a Neutral and lowers the price target from $9 to $6.5.
Citigroup Maintains Buy on DISH Network, Lowers Price Target to $18
Citigroup analyst Michael Rollins maintains DISH Network (NASDAQ:DISH) with a Buy and lowers the price target from $33 to $18.
Chardan Capital Maintains Buy on Provention Bio, Lowers Price Target to $25
Chardan Capital analyst Geulah Livshits maintains Provention Bio (NASDAQ:PRVB) with a Buy and lowers the price target from $30 to $25.
Morgan Stanley Maintains Equal-Weight on Arhaus, Lowers Price Target to $11
Morgan Stanley analyst Simeon Gutman maintains Arhaus (NASDAQ:ARHS) with a Equal-Weight and lowers the price target from $12 to $11.
Morgan Stanley Maintains Overweight on American Well, Lowers Price Target to $5
Morgan Stanley analyst Craig Hettenbach maintains American Well (NYSE:AMWL) with a Overweight and lowers the price target from $6 to $5.
Goldman Sachs Maintains Neutral on Reliance Steel & Aluminum, Raises Price Target to $270
Goldman Sachs analyst Kate McShane maintains Reliance Steel & Aluminum (NYSE:RS) with a Neutral and raises the price target from $245 to $270.
Goldman Sachs Maintains Neutral on Invesco, Lowers Price Target to $19
Goldman Sachs analyst Alexander Blostein maintains Invesco (NYSE:IVZ) with a Neutral and lowers the price target from $20 to $19.